ADXN logo

Addex Therapeutics Ltd (ADXN)

Profile

Full Name

Addex Therapeutics Ltd

Ticker Symbol

ADXN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Switzerland

IPO

February 12, 2020

Indexes

Not included

Website

http://www.addextherapeutics.com

Employees

23

Key Details

Price

$7.50(+0.94%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.80M(+20.44% YoY)

Annual EPS

-$18.71(+67.67% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.50
ADXN price is $7.50

30-Day Relative Volume

0.44
ADXN 30-day relative volume is 0.44

Price Performance

Price Most recent change

+0.94%
ADXN price was up +0.94% on Apr 17, 2025

Price YTD change

+7.14%
ADXN price is up +7.14% since January 1st

Price 1-year change

-65.91%
ADXN price is down -65.91% year-on-year

Price 3-year change

-91.45%
ADXN price is down -91.45% over the past 3 years

Price Range

Price All-time high

$750.40
ADXN price is currently -99.00% below its historical high of $750.40

Price 3-year low

$5.00
ADXN price is currently +50.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$8.02M
ADXN market capitalization is $8.02 million

Market cap 3-year change

-71.06%
ADXN market capitalization is down -71.06% over the past 3 years

Market cap All-time high

$106.92M
ADXN market capitalization is currently -92.50% below its historical high of $106.92 million

Market cap sector rank

17.2%
ADXN market capitalization is higher than 17.2% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.01%
ADXN shares outstanding is up +0.01% year-on-year

Shares Outstanding 3-Year Change

+238.61%
ADXN shares outstanding is up +238.61% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.40
ADXN beta is 0.40

200-day SMA

$8.49
ADXN price is currently -11.66% below its 200-day simple moving average

50-day SMA

$7.53
ADXN price is currently -0.40% below its 50-day simple moving average

RSI

51.93
ADXN 14-day relative strength index is 51.93

Volume

0.44
ADXN 30-day relative volume is 0.44

ATR

$0.53
ADXN average true range is $0.53

10-day Historical Volatility

79.81%
ADXN 10-day historical volatility is 79.81%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.80M
ADXN annual revenue is $1.80 million

Revenue Analysts estimate

$1.50M
ADXN annual revenue is currently +19.75% higher than the consensus analysts' forecast

Revenue 1-year change

+20.44%
ADXN annual revenue is up +20.44% year-on-year

Revenue Sector rank

14.91%
ADXN annual revenue is higher than 14.91% of companies in Healthcare sector

EPS

EPS

-$18.71
ADXN annual earnings per share is -$18.71

EPS Analysts estimate

-
ADXN annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+67.67%
ADXN annual earnings per share is up +67.67% year-on-year

EPS Sector rank

7.79%
ADXN annual earnings per share is higher than 7.79% of companies in Healthcare sector

Profit

Gross profit

-
ADXN annual gross profit value is unknown

Gross margin

-
ADXN annual gross profit margin value is unknown

Operating profit

-$11.45M
ADXN annual operating income is -$11.45 million

Operating margin

-637.43%
ADXN annual operating profit margin is -637.43%

Net income

-$11.76M
ADXN annual net profit is -$11.76 million

Net margin

-654.47%
ADXN annual net profit margin is -654.47%

Expenses

Total expenses

$13.25M
ADXN annual total expenses is $13.25 million

Operating expenses

$13.25M
ADXN annual total operating expenses is $13.25 million

Cost of goods sold

-
ADXN annual cost of goods sold value is unknown

Selling, general & administrative expenses

$8.02M
ADXN annual SGA is $8.02 million

Depreciation and amortization

$340.70K
ADXN annual depreciation & amortization is $340.70 thousand

Interest expense

$24.10K
ADXN annual interest expense is $24.10 thousand

Income tax

$0.00
ADXN annual income tax is $0.00

EBIT & EBITDA

EBIT

-$11.73M
ADXN annual earnings before interest & taxes is -$11.73 million

EBITDA

-$11.39M
ADXN annual EBITDA is -$11.39 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$5.53M
ADXN annual total assets is $5.53 million

Non current assets

$484.90K
ADXN annual long term assets is $484.90 thousand

Current assets

$5.04M
ADXN annual total current assets is $5.04 million

Cash and cash equivalents

$4.60M
ADXN annual cash & cash equivalents is $4.60 million

Accounts receivable

$131.40K
ADXN annual accounts receivable is $131.40 thousand

Inventory

-
ADXN annual inventory value is unknown

Liabilities

Total liabilities

$4.16M
ADXN annual total liabilities is $4.16 million

Long term liabilities

$718.10K
ADXN annual total long term liabilities is $718.10 thousand

Current liabilities

$3.44M
ADXN annual total current liabilities is $3.44 million

Accounts payable

$1.17M
ADXN annual accounts payable is $1.17 million

Debt

Total debt

$410.00K
ADXN annual total debt is $410.00 thousand

Total debt 1-year change

+1.86%
ADXN annual total debt is up +1.86% year-on-year

Long term debt

$83.80K
ADXN annual long term debt is $83.80 thousand

Short term debt

$326.20K
ADXN annual short term debt is $326.20 thousand

Equity & Capital

Shareholders equity

$1.36M
ADXN annual stockholders equity is $1.36 million

Book value

$1.36M
ADXN annual book value is $1.36 million

Retained earnings

-$429.10M
ADXN annual retained earnings is -$429.10 million

Working capital

$1.60M
ADXN annual working capital is $1.60 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$8.90M
ADXN annual cash flow from operations is -$8.90 million

Cash from operations 1-year change

+48.36%
ADXN annual cash flow from operations is up +48.36% year-on-year

Cash from investing

-$7600.00
ADXN annual cash flow from investing activities is -$7600.00

Cash from investing 1-year change

-345.16%
ADXN annual cash flow from investing activities is down -345.16% year-on-year

Cash from financing

$5.86M
ADXN annual cash flow from financing activities is $5.86 million

Cash from financing 1-year change

+80.22%
ADXN annual cash flow from financing activities is up +80.22% year-on-year

CAPEX

CAPEX

$7600.00
ADXN annual capital expenditures is $7600.00

CAPEX 1-year change

+1166.67%
ADXN annual capital expenditures is up +1166.67% year-on-year

Free Cash Flow

Free cash flow

-$8.91M
ADXN annual free cash flow is -$8.91 million

Free cash flow 1-year change

+48.31%
ADXN annual free cash flow is up +48.31% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ADXN annual gross profit margin value is unknown

Operating margin

-637.43%
ADXN annual operating profit margin is -637.43%

Net margin

-654.47%
ADXN annual net profit margin is -654.47%

ROA & ROE

ROA

-162.61%
ADXN annual return on assets is -162.61%

ROE

-352.89%
ADXN annual return on equity is -352.89%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ADXN price to earnings ratio value is unknown

PE ratio Sector rank

-
ADXN price to earnings ratio is unknown

PB Ratio

PB ratio

0.61
ADXN price to book ratio is 0.61

PB ratio Sector rank

32.98%
ADXN price to book ratio is higher than 32.98% of companies in Healthcare sector

PS Ratio

PS ratio

12.73
ADXN price to sales ratio is 12.73

PS ratio Sector rank

82.28%
ADXN price to sales ratio is higher than 82.28% of companies in Healthcare sector

Enterprise value

Enterprise value

$4.09M
ADXN enterprise value is $4.09 million

Enterprise value Sector rank

18.02%
ADXN enterprise value is higher than 18.02% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.30
ADXN EV/EBITDA is -0.30

EV/EBITDA Sector rank

56.05%
ADXN EV/EBITDA is higher than 56.05% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.46
ADXN annual current ratio is 1.46

Quick ratio

-
ADXN annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ADXN annual debt to equity ratio is 0.00

Interest coverage ratio

-486.80
ADXN annual interest coverage ratio is -486.80

Risk & Stability

Piotroski F-Score

-
ADXN piotroski f-score value is unknown

Altman Z-Score

-113.88
ADXN altman z-score is -113.88

Analyst ratings

Recent major analysts updates

Jul 31, 24 HC Wainwright & Co.
Buy
Jun 23, 22 HC Wainwright & Co.
Neutral
May 31, 22 HC Wainwright & Co.
Buy
Feb 11, 22 HC Wainwright & Co.
Buy
Apr 21, 21 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

CARM logo
Carisma Therapeutics (CARM)
MHUA logo
Meihua International Medical Technologies Co (MHUA)
HCWB logo
HCW Biologics (HCWB)
APRE logo
Aprea Therapeutics (APRE)
Dogwood Therapeutics (DWTX)
PMCB logo
PharmaCyte Biotech (PMCB)
OSA logo
ProSomnus (OSA)
ACXP logo
Acurx Pharmaceuticals (ACXP)
Scienture Holdings (SCNX)
  • What is the ticker symbol for Addex Therapeutics Ltd?
  • Does Addex Therapeutics Ltd pay dividends?
  • What sector is Addex Therapeutics Ltd in?
  • What industry is Addex Therapeutics Ltd in?
  • What country is Addex Therapeutics Ltd based in?
  • When did Addex Therapeutics Ltd go public?
  • Is Addex Therapeutics Ltd in the S&P 500?
  • Is Addex Therapeutics Ltd in the NASDAQ 100?
  • Is Addex Therapeutics Ltd in the Dow Jones?
  • When was Addex Therapeutics Ltd's last earnings report?
  • When does Addex Therapeutics Ltd report earnings?

What is the ticker symbol for Addex Therapeutics Ltd?

The ticker symbol for Addex Therapeutics Ltd is NASDAQ:ADXN

Does Addex Therapeutics Ltd pay dividends?

No, Addex Therapeutics Ltd does not pay dividends

What sector is Addex Therapeutics Ltd in?

Addex Therapeutics Ltd is in the Healthcare sector

What industry is Addex Therapeutics Ltd in?

Addex Therapeutics Ltd is in the Biotechnology industry

What country is Addex Therapeutics Ltd based in?

Addex Therapeutics Ltd is headquartered in Switzerland

When did Addex Therapeutics Ltd go public?

Addex Therapeutics Ltd's initial public offering (IPO) was on February 12, 2020

Is Addex Therapeutics Ltd in the S&P 500?

No, Addex Therapeutics Ltd is not included in the S&P 500 index

Is Addex Therapeutics Ltd in the NASDAQ 100?

No, Addex Therapeutics Ltd is not included in the NASDAQ 100 index

Is Addex Therapeutics Ltd in the Dow Jones?

No, Addex Therapeutics Ltd is not included in the Dow Jones index

When was Addex Therapeutics Ltd's last earnings report?

Addex Therapeutics Ltd's most recent earnings report was on Aug 18, 2022

When does Addex Therapeutics Ltd report earnings?

The date for Addex Therapeutics Ltd's next earnings report has not been announced yet
On this page